Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

• Status: Completed
• Trial end date: 1969-12-31

Summary

The main goal of this study is to evaluate and to determine the dose of a highly accurate irradiation (allowing to increase the dose delivered while restricting the risk of complication) in association with temozolomide.

• Phase: Phase 1

Details

• Lead Sponsor: Centre Georges Francois Leclerc
• Collaborator: Ligue contre le cancer, France
• Treatments: Dacarbazine; Temozolomide